Keurig Dr Pepper has turned a single share into two, and in the process has rewritten its own balance sheet, its management team, and its risk profile in a way the market is only beginning to price. The company closed the cash acquisition of JDE Peet's for roughly $17.4 billion in early 2026. It has since announced a plan to separate into two independent public companies, Beverage Co. and Global Coffee Co., targeted for early 2027. The central investment debate is whether the combined entity, loaded with debt at a projected 4.1x pro-forma management leverage at year-end, can execute the integration, capture the promised cost synergies, and deliver the low-double-digit adjusted EPS growth that underpins the case for both spin-offs.
The most consequential recent development is the sale of the company's entire Chobani stake and the Allentown, Pennsylvania facility for $925 million in pre-tax proceeds. The deal was announced on August 28, and the proceeds are earmarked for deleveraging. The transaction converts a minority investment and a manufacturing asset into cash while preserving a distribution and licensing relationship with Chobani's La Colombe brand through KDP's direct store delivery network. This is a deliberate act of balance sheet repair. It comes just weeks after the company reaffirmed its full-year guidance, which calls for net sales between $25.9 billion and $26.4 billion.
The tension sits in the gap between the operating story and the capital structure. Legacy KDP net sales grew 7.3% in the second quarter, led by U.S. Refreshment Beverages, while the U.S. Coffee segment fell 3.2% on soft single-serve volumes and price elasticity. At the consolidated level, GAAP diluted EPS was $0.04 for the quarter versus $0.40 a year earlier, and net interest expense more than doubled. The adjusted EPS line, at $0.57, looks healthy, but it rests on productivity savings and JDE Peet's contribution rather than on the core coffee business, which is the segment most exposed to the category headwinds that have plagued single-serve for three straight years.
The catalyst is the separation itself, expected in early 2027, and the quarterly evidence of deleveraging toward the 4.1x leverage target. The Chobani sale closes in the third quarter, and each subsequent quarter's free cash flow print determines whether the balance sheet can absorb the full-year interest burden without a further rating action. The stock at $31.75, with a market cap near $43 billion, is paying for a transformation that is half complete.